But now, Abbott’s FreeStyle Libre 2 and 3 have received the first and only FDA clearance that allows patients to keep their ...

This multi-device solution supports Abbott’s FreeStyle Libre portfolio within Epic and Oracle Health EHR systems, marking a significant leap forward in how healthcare providers access and utilize ...

The US Food and Drug Administration has okayed removal of the contraindication for use during CT and MRI under certain ...

Users of the FreeStyle Libre 2 and 3 continuous glucose monitoring systems from Abbott no longer need to remove and discard the devices for imaging procedures, such as X-rays, CT ...

Abbott announced today that the FDA said users can wear the FreeStyle Libre 2 and 3 CGMs during common imaging procedures.

Beta Bionics announced today that it launched the integration of the iLet bionic pancreas with the Abbott (NYSE:ABT) ...

A major development towards the goal of patient and provider choice, the cloud-to-cloud integration will provide an automatic ...

Beta Bionics has launched the integration of its flagship iLet Bionic Pancreas with Abbott’s FreeStyle Libre 3 Plus sensor.

Combine continuous glucose monitoring data from the FreeStyle Libre 2 system, from wherever you are*, along with expert advice from your health coach help you make informed decisions to keep enjoying ...

We expect the company to post a mid-single-digit uptick in revenue, driven by higher FreeStyle Libre sales. Our interactive dashboard analysis of Abbott’s FY 2024Q3 Earnings Preview has more ...

IRVINE, CA / ACCESSWIRE / October 30, 2024 / Beta Bionics, Inc., a pioneering leader in the development of advanced diabetes ...

Tidepool collaborates with Abbott for seamless data integration with its FreeStyle Libre portfolio in the U.S., expanding patient choice and streamlining diabetes care workflows. Tidepool ...